RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I.
Saved in:
| Title: | RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I. |
|---|---|
| Authors: | Tálas A; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Ioannidi EI; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Weber Y; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Haenggi T; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Kulcsár PI; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Zürcher N; Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Faccin E; Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Moon WJ; Acuitas Therapeutics Inc., Vancouver, BC, Canada., Kissling L; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Villiger EA; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Matsushita M; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Rothgangl T; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Janjuha S; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Lin PJC; Acuitas Therapeutics Inc., Vancouver, BC, Canada., Poms M; Division of Clinical Chemistry and Biochemistry, University Children's Hospital Zurich, Zurich, Switzerland., Muramatsu H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Vadovics M; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Reichmuth A; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Kopf M; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Tam YK; Acuitas Therapeutics Inc., Vancouver, BC, Canada., Häberle J; Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Schwank G; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. |
| Source: | Science translational medicine [Sci Transl Med] 2026 May 13; Vol. 18 (849), pp. eaec7274. Date of Electronic Publication: 2026 May 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42127219 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tálas+A%22">Tálas A</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ioannidi+EI%22">Ioannidi EI</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Weber+Y%22">Weber Y</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Haenggi+T%22">Haenggi T</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kulcsár+PI%22">Kulcsár PI</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zürcher+N%22">Zürcher N</searchLink>; Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Faccin+E%22">Faccin E</searchLink>; Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Moon+WJ%22">Moon WJ</searchLink>; Acuitas Therapeutics Inc., Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Kissling+L%22">Kissling L</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Villiger+EA%22">Villiger EA</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Matsushita+M%22">Matsushita M</searchLink>; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rothgangl+T%22">Rothgangl T</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Janjuha+S%22">Janjuha S</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lin+PJC%22">Lin PJC</searchLink>; Acuitas Therapeutics Inc., Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Poms+M%22">Poms M</searchLink>; Division of Clinical Chemistry and Biochemistry, University Children's Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Muramatsu+H%22">Muramatsu H</searchLink>; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Vadovics+M%22">Vadovics M</searchLink>; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Reichmuth+A%22">Reichmuth A</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kopf+M%22">Kopf M</searchLink>; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pardi+N%22">Pardi N</searchLink>; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Tam+YK%22">Tam YK</searchLink>; Acuitas Therapeutics Inc., Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Häberle+J%22">Häberle J</searchLink>; Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schwank+G%22">Schwank G</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101505086%22">Science translational medicine</searchLink> [Sci Transl Med] 2026 May 13; Vol. 18 (849), pp. eaec7274. <i>Date of Electronic Publication: </i>2026 May 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101505086 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1946-6242 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219466234%22">19466234 </searchLink><i>NLM ISO Abbreviation: </i>Sci Transl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42127219 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1126/scitranslmed.aec7274 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: eaec7274 Titles: – TitleFull: RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tálas A – PersonEntity: Name: NameFull: Ioannidi EI – PersonEntity: Name: NameFull: Weber Y – PersonEntity: Name: NameFull: Haenggi T – PersonEntity: Name: NameFull: Kulcsár PI – PersonEntity: Name: NameFull: Zürcher N – PersonEntity: Name: NameFull: Faccin E – PersonEntity: Name: NameFull: Moon WJ – PersonEntity: Name: NameFull: Kissling L – PersonEntity: Name: NameFull: Villiger EA – PersonEntity: Name: NameFull: Matsushita M – PersonEntity: Name: NameFull: Rothgangl T – PersonEntity: Name: NameFull: Janjuha S – PersonEntity: Name: NameFull: Lin PJC – PersonEntity: Name: NameFull: Poms M – PersonEntity: Name: NameFull: Muramatsu H – PersonEntity: Name: NameFull: Vadovics M – PersonEntity: Name: NameFull: Reichmuth A – PersonEntity: Name: NameFull: Kopf M – PersonEntity: Name: NameFull: Pardi N – PersonEntity: Name: NameFull: Tam YK – PersonEntity: Name: NameFull: Häberle J – PersonEntity: Name: NameFull: Schwank G IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 05 Text: 2026 May 13 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1946-6242 Numbering: – Type: volume Value: 18 – Type: issue Value: 849 Titles: – TitleFull: Science translational medicine Type: main |
| ResultId | 1 |